NEW YORK (GenomeWeb) – Danaher today reported that its fourth quarter revenues rose nearly 13 percent year over year.

The company said revenues increased to $5.88 billion for the three months ended Dec. 31, 2015, from $5.22 billion a year ago, but it missed analysts' consensus estimate of $6.00 billion in revenues for the quarter.

The firm's net earnings for the quarter were $688.6 million, or $.99 per share, compared to $661.7 million, or $.92 per share, for Q4 2014. Its adjusted earnings per share was $1.27 for the quarter, matching the consensus Wall Street estimate.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.